H
Harlan M. Krumholz
Researcher at Yale University
Publications - 1966
Citations - 177853
Harlan M. Krumholz is an academic researcher from Yale University. The author has contributed to research in topics: Myocardial infarction & Population. The author has an hindex of 85, co-authored 1826 publications receiving 159216 citations. Previous affiliations of Harlan M. Krumholz include Veterans Health Administration & Robert Wood Johnson Foundation.
Papers
More filters
Journal ArticleDOI
Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group.
Douglas D. Schocken,Emelia J. Benjamin,Gregg C. Fonarow,Harlan M. Krumholz,Daniel Levy,George A. Mensah,Jagat Narula,Eileen Stuart Shor,James B. Young,Yuling Hong +9 more
TL;DR: In this article, the authors proposed to identify and treat patients with asymptomatic left ventricular systolic dysfunction (Stage B HF) and how to prevent its development.
Journal ArticleDOI
Monitoring clinical changes in patients with heart failure: a comparison of methods.
John A. Spertus,Eric D. Peterson,Mark W. Conard,Paul A. Heidenreich,Harlan M. Krumholz,Philip G. Jones,Peter A. McCullough,Ileana L. Piña,Joseph F. Tooley,William S. Weintraub,John S. Rumsfeld +10 more
TL;DR: The Kansas City Cardiomyopathy Questionnaire, followed by the New York Heart Association and the 6-minute walk test, most accurately reflected clinical change in patients with heart failure.
Journal ArticleDOI
The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure.
Jeptha P. Curtis,Seth I. Sokol,Yongfei Wang,Saif S. Rathore,Dennis T. Ko,Farid Jadbabaie,Edward L. Portnay,Stephen J Marshalko,Martha J. Radford,Harlan M. Krumholz +9 more
TL;DR: Among HF patients in sinus rhythm, higher LVEFs were associated with a linear decrease in mortality up to an LVEF of 45%, however, increases above 45% were not associated with further reductions in mortality.
Journal ArticleDOI
Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction.
Dennis T. Ko,Patricia R. Hebert,Christopher S. Coffey,Artyom Sedrakyan,Jeptha P. Curtis,Harlan M. Krumholz +5 more
TL;DR: The conventional wisdom that β-blocker therapy is associated with substantial risks of depressive symptoms, fatigue, and sexual dysfunction is not supported by data from clinical trials.
Journal ArticleDOI
Predictors of readmission among elderly survivors of admission with heart failure.
TL;DR: Few patient and clinical factors predict readmission within 6 months after discharge in elderly patients with heart failure, and a group of high-risk patients were identified for whom resource-intensive interventions designed to improve outcomes may be justified.